Patents by Inventor Lawrence Cioffi

Lawrence Cioffi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8501729
    Abstract: Novel 5-HT3 receptor modulators are disclosed. These compounds are used in the treatment of various disorders, including chemotherapy-induced nausea and vomiting, post-operative nausea and vomiting, and irritable bowel syndrome. Methods of making these compounds are also described in the present invention.
    Type: Grant
    Filed: February 14, 2012
    Date of Patent: August 6, 2013
    Assignee: Albany Molecular Research, Inc.
    Inventors: David D. Manning, Christopher Lawrence Cioffi
  • Publication number: 20120219641
    Abstract: Novel 5-HT3 receptor modulators are disclosed. These compounds are used in the treatment of various disorders, including chemotherapy-induced nausea and vomiting, post-operative nausea and vomiting, and irritable bowel syndrome. Methods of making these compounds are also described in the present invention.
    Type: Application
    Filed: February 14, 2012
    Publication date: August 30, 2012
    Applicant: ALBANY MOLECULAR RESEARCH, INC.
    Inventors: David D. Manning, Christopher Lawrence Cioffi
  • Patent number: 8124600
    Abstract: Novel 5-HT3 receptor modulators are disclosed. These compounds are used in the treatment of various disorders, including chemotherapy-induced nausea and vomiting, post-operative nausea and vomiting, and irritable bowel syndrome. Methods of making these compounds are also described in the present invention.
    Type: Grant
    Filed: May 28, 2009
    Date of Patent: February 28, 2012
    Assignee: Albany Molecular Research, Inc.
    Inventors: David D. Manning, Christopher Lawrence Cioffi
  • Publication number: 20100204207
    Abstract: Compounds of Formula (I): wherein n, m, p, q, Y, R1, R2, R3a, R3b, R4, R5, and R6 are as defined herein and their pharmaceutical compositions and methods of use are disclosed.
    Type: Application
    Filed: April 20, 2010
    Publication date: August 12, 2010
    Inventors: Xinchao Chen, Christopher Lawrence Cioffi, Sean Richard Dinn, Ana Maria Escribano, Maria Carmen Fernandez, Todd Fields, Robert Jason Herr, Nathan Bryan Mantlo, Eva Maria Martin De La Nava, Ana Isabel Mateo Herranz, Saravanan Parthasarathy, Xiaodong Wang
  • Patent number: 7749992
    Abstract: Compounds of formula I wherein n, m, p, q, y, R1 R2, R3, R4, R5, and R6 are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating artherosclerosis and its sequelae.
    Type: Grant
    Filed: October 7, 2004
    Date of Patent: July 6, 2010
    Assignee: Eli Lilly and Company
    Inventors: Guoqing Cao, Ana Maria Escribano, Maria Carmen Fernandez, Todd Fields, Douglas Linn Gernert, Christopher Lawrence Cioffi, Robert Jason Herr, Nathan Bryan Mantlo, Eva Maria Martin De La Nava, Ana Isabel Mateo Herranz, Daniel Ray Mayhugh, Xiaodong Wang
  • Publication number: 20090298809
    Abstract: Novel 5-HT3 receptor modulators are disclosed. These compounds are used in the treatment of various disorders, including chemotherapy-induced nausea and vomiting, post-operative nausea and vomiting, and irritable bowel syndrome. Methods of making these compounds are also described in the present invention.
    Type: Application
    Filed: May 28, 2009
    Publication date: December 3, 2009
    Applicant: Albany Molecular Research, Inc.
    Inventors: David D. Manning, Christopher Lawrence Cioffi
  • Patent number: 5676738
    Abstract: A new synthetic, pyrolized, spherical adsorbent, with a moving or fluidized bed VOC control/solvent recovery system, also described as a control/solvent recovery system.
    Type: Grant
    Filed: August 22, 1995
    Date of Patent: October 14, 1997
    Inventors: Lawrence Cioffi, Harold R. Cowles